Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
12/2009
12/22/2009US7635467 Mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof
12/22/2009CA2447166C Delivery of erectile dysfunction drugs through an inhalation route
12/22/2009CA2446990C Delivery of sedative-hypnotics through an inhalation route
12/22/2009CA2446917C Delivery of antipsychotics through an inhalation route
12/22/2009CA2446916C Delivery of opioids through an inhalation route
12/22/2009CA2416527C Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
12/22/2009CA2330976C Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides, novel compounds thereof and their use as chemotherapeutic agents
12/17/2009WO2009152087A1 Bicyclic heteroaryl compounds and methods for kinase modulation, and indications therefor
12/17/2009WO2009152083A1 5h-pyrr0l0 [2,3-b] pyrazine derivatives for kinase modulation, and indications therefor
12/17/2009WO2009151997A1 Process for producing bicycloaniline derivatives
12/17/2009WO2009151561A2 Methods and compounds for antimicrobial intervention
12/17/2009WO2009150388A1 Novel derivatives of (bridged piperazinyl)-1-alcanone and use thereof as p75 inhibitors
12/17/2009WO2009121036A3 Substituted aryl pyrimidinone derivatives
12/17/2009WO2009091374A3 Fused heterocyclic derivatives and methods of use as c-met inhibitors
12/17/2009WO2009071899A3 Supramolecular handcuffs in polymeric architecture
12/17/2009US20090312543 Pyrazole compounds useful as protein kinase inhibitors
12/17/2009US20090312539 An improved process for the preparation of carbapenem antibiotic
12/17/2009US20090312390 Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma
12/17/2009US20090312365 Certain Chemical Entities, Compositions, and Methods
12/17/2009US20090312338 Novel Tricyclic Compounds
12/17/2009US20090312336 Dihydropteridine compounds as anti proliferative agents
12/17/2009US20090312334 Immunomodulating Heterocyclic Compounds
12/17/2009US20090312331 PROCESS FOR PREPARING SALTS OF 4-[[5-[(CYCLOPROPYLAMINO)CARBONYL]-2-METHYLPHENYL]AMINO]-5-METHYL-N-PROPYLPYRROLO[2,1-f][1,2,4]TRIAZINE-6-CARBOXAMIDE AND NOVEL STABLE FORMS PRODUCED THEREIN
12/17/2009US20090312321 Compositions and methods for fgf receptor kinases inhibitors
12/17/2009US20090312319 Certain chemical entities, compositions and methods
12/17/2009US20090312312 Heterobicyclic Metalloprotease Inhibitors
12/17/2009US20090311288 Imidazoquinoxaline compounds as immunomodulators
12/17/2009US20090311176 2-Arylpyrazolo[L,5-Alpha] Pyrimidin-3-YL Acetamide Derivatives as Ligands for Translocator Protein (18 Kda)
12/17/2009US20090309488 Material for organic electroluminescence device and organic electroluminescence device using the same
12/17/2009CA2727684A1 Diamino-pyridine, pyrimidine, and pyridazine modulators of the histamine h4 receptor
12/17/2009CA2727669A1 Novel derivatives of (bridged piperazinyl)-1-alcanone and use thereof as p75 inhibitors
12/17/2009CA2727389A1 5h-pyrrolo [2,3-b] pyrazine derivatives for kinase modulation, and indications therefor
12/17/2009CA2727032A1 Novel tricyclic compounds
12/16/2009EP2131844A1 PTERIDINONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
12/16/2009EP2131656A2 Phthalazine derivatives
12/16/2009CN101605793A Azabicycloalkane derivatives, preparation thereof and use thereof in therapy
12/16/2009CN101605764A Fast dissociating dopamine 2 receptor antagonists
12/16/2009CN101602747A Preparation and application of 3, 7-disubstituted-N-hexyl phenothiazine derivative
12/16/2009CN101602746A Preparation and application of 3-substituted-N-hexyl phenothiazine derivative
12/16/2009CN101602741A Substituted n-arylsulfonylheterocyclic amines as gamma-secretase inhibitors
12/16/2009CN100569776C Topoisomerase enzyme inhibitor, preparation method and application thereof
12/16/2009CN100569775C Method for crystal form conversion of zopiclone
12/15/2009US7632954 Substituted sym-triindole
12/15/2009US7632947 in which an oligothiophene having p-type semiconductor characteristics may be bonded to a pyrimidopyrimidine having n-type semiconductor characteristics positioned in the center of the molecules, thereby exhibiting both p-type and n-type semiconductor characteristics; higher charge carrier mobility
12/15/2009US7632837 6-(2-Chlorophenyl)-7-(4-chlorophenyl)-N-cyclohexyl-[1,2,4]triazolo[4,3-b]pyridazin-3-amine; drug abuse, drug dependency; smoking cigarettes; appetite suppressants; antilipemic agents; anticholesterol agents; increasing high density lipoproteins;hypotensive agents; antidiabetic agents
12/15/2009US7632831 1H-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof
12/15/2009US7632830 Lactam compounds and pharmaceutical use thereof
12/15/2009US7632576 Aryl-aryl dendrimers
12/15/2009CA2398908C Adenosine a2a receptor antagonists for treating and preventing hepatic fibrosis, cirrhosis and fatty liver
12/15/2009CA2345295C Use of fused pyrrolocarbazoles in preventing/treating damage to sensory hair cells and cochlear neurons
12/10/2009WO2009148192A1 Alpha helix mimetics and methods relating thereto
12/10/2009WO2009148062A1 Polycyclic compound and organic electroluminescent device using the same
12/10/2009WO2009148016A1 Halogen compound, polycyclic compound and organic electroluminescent element using the polycyclic compound
12/10/2009WO2009148015A1 Halogen compound, polycyclic compound, and organic electroluminescence element comprising the polycyclic compound
12/10/2009WO2009098715A4 Novel pyrazolo [3, 4 -d] pyrimidine derivatives as anti -cancer agents
12/10/2009WO2008146172A3 Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
12/10/2009US20090306381 Mono Amine and Diamine Derivatives of CL-20
12/10/2009US20090306374 Fused heterocyclic derivative and use thereof
12/10/2009US20090306369 Process for preparing benzazepine compounds or salts thereof
12/10/2009US20090306362 Methyl aquocobyrinic acid derivative, alkylation composition, and method for detoxifying a harmful compound by utilizing the composition
12/10/2009US20090306134 Muscarinic receptor antagonists
12/10/2009US20090306127 Certain Chemical Entities, Compositions and Methods
12/10/2009US20090306123 Bicyclononene derivaties
12/10/2009US20090306087 Compounds and Methods for Kinase Modulation, and Indications Therefor
12/10/2009US20090306067 2, 4-diaminopyrimidide derivates and their use for the treatment of cancer
12/10/2009US20090305891 Cycloalkylphenyl substituted cyclic ketoenols
12/10/2009US20090304629 Macrocyclic hepatitis c serine protease inhibitors
12/10/2009US20090302742 Compound for Use in Organic Electroluminescent Device and Organic Electroluminescent Device
12/10/2009CA2726673A1 Alpha helix mimetics and methods relating thereto
12/09/2009EP2130828A1 Sulfonamide derivative
12/09/2009EP2130822A1 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between p53 and mdm2 proteins for use as anticancer agents
12/09/2009EP2129674A2 Solid forms of pemetrexed
12/09/2009EP1735309B1 An improved process for the preparation of n-([1,2,4]triazolopyrimidin-2-yl)aryl sulfonamides
12/09/2009EP1692140B1 Compositions useful as inhibitors of protein kinases
12/09/2009EP1519939B1 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof
12/09/2009EP1409450B1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
12/09/2009CN101600719A Enantioselective synthesis of 6-amino-7-hydroxy-4, 5, 6, 7-tetrahydro-imidazo [4, 5, 1-jk] [1] -benzazepin-2 [1h] -one and zilpaterol
12/09/2009CN101600718A Imidazo[1,2-B]pyridazine and pyrazolo[1,5-A]pyrimidine derivatives and their use as protein kinase inhibitors
12/09/2009CN101600350A Use of azolopyrimidines for fighting plant pathogenic fungi
12/09/2009CN101596191A Method for treatment of disease using malonyl-coa decarboxylase inhibitor
12/09/2009CN100567301C Chlorophyll derivatives, preparation method and application thereof in medical agricultural chemicals
12/09/2009CN100567300C Reactive metal phthalocyanine derivative and its preparation
12/09/2009CN100567299C New antifungal compound, preparation method and application
12/09/2009CN100567298C Method for synthesizing polyhydroxy hyacinthacine alkaloid
12/09/2009CN100567297C 6-halogeno-[1,2,4]triazolo[1,5-a]pyrimidines for combating animal pests
12/09/2009CN100567296C Triazolopyridazines as inhibitors of protein kinases
12/09/2009CN100567293C N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists
12/09/2009CN100567273C Organic compounds
12/09/2009CN100567271C Improved purification of 4,4'(5')-di-t-butylcyclohexano-18-crown-6
12/09/2009CN100567270C Sulfonyl amide derivatives
12/08/2009US7629606 Zinc based porphyrins, biladienone derivatives; reduced contact resistance
12/08/2009US7629468 Neuroprotectants, analgesics or anticonvulsants
12/08/2009US7629462 Such as (5-Aminomethyl-2-methylsulfanyl-6-phenyl-pyrimidin-4-yl)-phenylamine; p38 map kinase inhibitors
12/08/2009US7629459 Azo dye compound
12/08/2009US7629350 CSBP/p38 kinase inhibitor; antiinflammatory agent; inflammatory bowel disease; tuberculosis, atherosclerosis, muscle degeneration, cachexia, psoriatic arthritis, rheumatoid arthritis; 8-(2,4,6-trifluorophenyl)-4-(2,4-difluorophenyl)-2-(2-hydroxy-1-hydroxymethylethylamino)-8H-pyridio[2,3]pyrimidin-7-one
12/08/2009US7629349 Parkinson's disease; antidepressants; cognition activators; analgesics; brain disorders; drug combination
12/08/2009US7629344 3-(imidazolyl)-pyrazolo[3,4-b]pyridines
12/08/2009US7629342 Regulation of appetite, antiemetics, immunosuppression, analgesia, inflammation, antinocioception, sedation, and intraocular pressure; synergistic; 2-(4-(Trifluoromethyl)benzyl)-7,8-bis(4-chlorophenyl)-6-(methylamino)-[1,2,4]triazolo[4,3-b]pyridazin-3(2H)-one
12/08/2009US7629337 Chemokine receptor binding heterocyclic compounds
12/08/2009US7629294 Pyrazolopyrimidines